Shanghai United Imaging Healthcare Co. Ltd. A
Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company's molecular imaging products include uEXPLORER, uPMR 790, uMI 780, uMI Panorama, uMI Panorama GS, uMI Vista, and uMI 550; its magnetic resonance imaging s… Read more
Shanghai United Imaging Healthcare Co. Ltd. A (688271) - Net Assets
Latest net assets as of June 2025: CN¥20.79 Billion CNY
Based on the latest financial reports, Shanghai United Imaging Healthcare Co. Ltd. A (688271) has net assets worth CN¥20.79 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥28.68 Billion) and total liabilities (CN¥7.89 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥20.79 Billion |
| % of Total Assets | 72.48% |
| Annual Growth Rate | 53.24% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 100.27 |
Shanghai United Imaging Healthcare Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how Shanghai United Imaging Healthcare Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shanghai United Imaging Healthcare Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Shanghai United Imaging Healthcare Co. Ltd. A from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥19.91 Billion | +5.43% |
| 2023-12-31 | CN¥18.88 Billion | +8.06% |
| 2022-12-31 | CN¥17.47 Billion | +247.14% |
| 2021-12-31 | CN¥5.03 Billion | +39.43% |
| 2020-12-31 | CN¥3.61 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai United Imaging Healthcare Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 550957925201.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥5.18 Billion | 26.04% |
| Other Components | CN¥14.72 Billion | 73.96% |
| Total Equity | CN¥19.90 Billion | 100.00% |
Shanghai United Imaging Healthcare Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shanghai United Imaging Healthcare Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pandora A/S
PINK:PNDZF
|
$5.76 Billion |
|
Ollie's Bargain Outlet Holdings Inc
F:OL6
|
$5.76 Billion |
|
Prosperity Bancshares Inc
NYSE:PB
|
$5.76 Billion |
|
Descartes Systems Group Inc
NASDAQ:DSGX
|
$5.77 Billion |
|
NEXTDC Limited
PINK:NXDCF
|
$5.76 Billion |
|
SYENSQO SA
OTCGREY:SHBBF
|
$5.76 Billion |
|
Stericycle Inc
NASDAQ:SRCL
|
$5.75 Billion |
|
St. James’s Place PLC
PINK:STJPF
|
$5.75 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai United Imaging Healthcare Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,866,353,650 to 19,903,165,418, a change of 1,036,811,768 (5.5%).
- Net income of 1,261,869,451 contributed positively to equity growth.
- Dividend payments of 303,596,850 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.26 Billion | +6.34% |
| Dividends Paid | CN¥303.60 Million | -1.53% |
| Other Changes | CN¥78.54 Million | +0.39% |
| Total Change | CN¥- | 5.50% |
Book Value vs Market Value Analysis
This analysis compares Shanghai United Imaging Healthcare Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.94x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 23.99x to 4.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥4.97 | CN¥119.28 | x |
| 2021-12-31 | CN¥6.96 | CN¥119.28 | x |
| 2022-12-31 | CN¥21.21 | CN¥119.28 | x |
| 2023-12-31 | CN¥22.89 | CN¥119.28 | x |
| 2024-12-31 | CN¥24.15 | CN¥119.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai United Imaging Healthcare Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.34%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.25%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.41x
- Recent ROE (6.34%) is below the historical average (15.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 25.08% | 15.67% | 0.60x | 2.68x | CN¥542.90 Million |
| 2021 | 28.13% | 19.54% | 0.70x | 2.06x | CN¥913.45 Million |
| 2022 | 9.47% | 17.93% | 0.38x | 1.38x | CN¥-92.24 Million |
| 2023 | 10.46% | 17.30% | 0.45x | 1.34x | CN¥87.66 Million |
| 2024 | 6.34% | 12.25% | 0.37x | 1.41x | CN¥-728.45 Million |
Industry Comparison
This section compares Shanghai United Imaging Healthcare Co. Ltd. A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai United Imaging Healthcare Co. Ltd. A (688271) | CN¥20.79 Billion | 25.08% | 0.38x | $5.76 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |